Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Maria Consuelo PintadoInmaculada Lasa UnzúeRemedios Gómez SanzManuel Diez AlonsoMiguel Ángel OrtegaMelchor Álvarez de MonEmilio Nevado LosadaAlberto Gutierrez CalvoPublished in: Journal of clinical medicine (2023)
In our study, 77.1% of patients treated with CRS and HIPEC developed hematological complications during the postoperative period; the majority of them were not severe and resolved spontaneously, without an effect on mortality or hospital stay.